GD
SEC Insider//CIK 0001182464
GOEDDEL DAVID V
CIK 000118246412 companiesSAN FRANCISCO, CA
Transactions
50
Companies
12
Filings
5
CIK
0001182464
Recent Transactions
- Award
- Purchase
Series A Warrant (right to buy)
2025-03-05+35,714,284→ 35,714,284 total - Purchase
Series B Warrant (right to buy)
2025-03-05+17,857,142→ 17,857,142 total - Purchase
- Other
- Other
- Other
- Other
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Other
- Disposition to Issuer
- Disposition to Issuer
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Award
- Award
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
Companies
12- $RCUS
Arcus Biosciences, Inc.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
eFFECTOR Therapeutics, Inc.
10% Owner
Gritstone bio, Inc.
Managing Partner
IMMUNE DESIGN CORP.
10% Owner
NGM BIOPHARMACEUTICALS INC
Director, 10% Owner
- $NRIX
Nurix Therapeutics, Inc.
10% Owner, Managing Partner
- $ORIC
Oric Pharmaceuticals, Inc.
10% Owner, Managing Partner
- $RAPT
RAPT Therapeutics, Inc.
Director, 10% Owner
- $RVMD
Revolution Medicines, Inc.
10% Owner, Managing Partner
- $TNYA
Tenaya Therapeutics, Inc.
Director, 10% Owner
TULARIK INC
Director, Chief Executive Officer
Recent Filings
5Address
1700 OWENS STREET, SUITE 500
SAN FRANCISCO, CA, 94158